SUPRIETY™️ RECOVERY RESOURCE DIRECTORY
"The Struggle Was Worth The Solution"
Curated by Joey Noble – built from lived experience, not corporate theory.

IMPORTANT REMINDER: The following information is educational only. Always consult licensed medical professionals before making treatment decisions.

────────────────────────────────────────
1. BRIXADI® RAPID INDUCTION (EXTENDED-RELEASE BUPRENORPHINE)
────────────────────────────────────────
• Official patient overview: https://www.brixadi.com/
• FDA approval announcement with prescribing details: https://www.fda.gov/news-events/press-announcements/fda-approves-first-extended-release-buprenorphine-injection-subcutaneous-use-treat-opioid-dependence
• Locate a BRIXADI provider: https://www.brixadi.com/treatment-locator/
• Prep questions for your clinician:
  - “What steps are required to move from short-acting opioids to BRIXADI safely?”
  - “Can we discuss rapid induction if withdrawal has been a barrier for me in the past?”
  - “How will we monitor cravings and stabilization after the first dose?”

────────────────────────────────────────
2. BERNese METHOD (LOW-DOSE BUPRENORPHINE INDUCTION)
────────────────────────────────────────
• Clinical case series (Lugoboni et al., 2020): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023950/
• Canadian guideline summary (British Columbia Centre on Substance Use): https://www.bccsu.ca/wp-content/uploads/2021/01/BERNese-Method-Summary.pdf
• Harm reduction microdosing explainer (Substance Use Health – Canada): https://substanceusehealth.ca/micro-dosing-buprenorphine
• Implementation checklist to review with care teams:
  1. Confirm any opioid agonist therapy conflicts and planned taper schedule.
  2. Establish daily microdosing increments and observation support.
  3. Schedule follow-up within 48–72 hours to evaluate comfort and cravings.

────────────────────────────────────────
3. FREE NARCAN® (NALOXONE) DISTRIBUTION NETWORKS
────────────────────────────────────────
• Mail-based access (NEXT Distro): https://www.nextdistro.org/
• National locator (NARCAN® Now): https://narcan.com/find-narcan
• Community distribution directory (Harm Reduction Coalition): https://harmreduction.org/resource-center/naloxone/
• Training & usage guides (CDC): https://www.cdc.gov/stopoverdose/naloxone/index.html
• Action steps:
  - Carry two doses and check expiration dates monthly.
  - Teach roommates, friends, or family to administer using the CDC video resources.
  - Log refill reminders in your phone or planner.

────────────────────────────────────────
4. PET FENTANYL SAFETY PROTOCOLS
────────────────────────────────────────
• Pet opioid exposure overview (American Veterinary Medical Association): https://www.avma.org/resources/pet-owners/petcare/poison-prevention-and-pets
• Emergency hotline (ASPCA Animal Poison Control Center – 24/7): https://www.aspca.org/pet-care/animal-poison-control | Phone: +1 (888) 426-4435 (consultation fees may apply)
• Exposure symptoms to monitor:
  - Sudden lethargy, pinpoint pupils, slowed breathing, unresponsiveness.
  - Residue on paws or fur after visiting public areas.
• Emergency response checklist:
  1. Remove any suspected substance safely (use gloves).
  2. Ventilate the area and prevent additional pet exposure.
  3. Contact a veterinarian or ASPCA hotline immediately; describe symptoms and timeline.
  4. Transport pets to emergency care if instructed—time is critical.

────────────────────────────────────────
5. METHADONE CLINIC & MEDICATION-ASSISTED TREATMENT LOCATORS
────────────────────────────────────────
• SAMHSA treatment locator (USA): https://findtreatment.gov/
• Opioid treatment program directory (SAMHSA OTP): https://dpt2.samhsa.gov/treatment/
• Department of Veterans Affairs SUD programs: https://www.va.gov/health-care/health-needs-conditions/substance-use-problems/
• Questions for clinics:
  - “What are intake requirements and wait times?”
  - “Do you offer split dosing or take-home privileges?”
  - “What counseling or peer groups are available on-site?”

────────────────────────────────────────
6. VIVITROL® (EXTENDED-RELEASE NALTREXONE) SAFETY SNAPSHOT
────────────────────────────────────────
• Official medication guide: https://www.vivitrol.com/
• SAMHSA overview of naltrexone: https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions/naltrexone
• Critical safety warnings to discuss with your provider:
  - Vivitrol requires 7–14 days opioid-free to avoid precipitated withdrawal.
  - Reduced tolerance increases overdose risk if relapse occurs—review overdose prevention strategies before injections.
  - Ask about liver function monitoring and emergency contacts.

────────────────────────────────────────
7. QUICK-ACCESS CHECKLIST
────────────────────────────────────────
☐ Save BRIXADI and Bernese Method links to share with your care team.
☐ Request free Narcan delivery and train two allies on administration.
☐ Print pet safety checklist; post near entryways if you have animals.
☐ Use findtreatment.gov to map clinics within 25 miles.
☐ Schedule a consult to discuss Vivitrol suitability (if relevant).
☐ Join Supriety™️ emails for ongoing lived-experience insights.

Stay resourced. Stay supported. The struggle was worth the solution.
